Found 8 results
Author [ Keyword(Asc)] Title Type Year
Filters: Keyword is Intestinal Mucosa  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Intestinal Mucosa
Ehrlich AK, Pennington JM, Tilton S, Wang X, Marshall NB, Rohlman D, Funatake C, Punj S, O'Donnell E, Yu Z et al..  2017.  AhR activation increases IL-2 production by alloreactive CD4 T cells initiating the differentiation of mucosal-homing Tim3 Lag3 Tr1 cells.. Eur J Immunol. 47(11):1989-2001.
Perera T, Young MR, Zhang Z, Murphy G, Colburn NH, Lanza E, Hartman TJ, Cross AJ, Bobe G.  2015.  Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.. Mol Nutr Food Res. 59(4):795-806.
Campbell Y, Fantacone ML, Gombart AF.  2012.  Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.. Eur J Nutr. 51(8):899-907.
Wang R, W Dashwood M, Löhr CV, Fischer KA, Nakagama H, Williams DE, Dashwood RH.  2008.  beta-catenin is strongly elevated in rat colonic epithelium following short-term intermittent treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high-fat diet.. Cancer Sci. 99(9):1754-9.
Mustacich DJ, Vo AT, Elias VD, Payne K, Sullivan L, Leonard SW, Traber MG.  2007.  Regulatory mechanisms to control tissue alpha-tocopherol.. Free Radic Biol Med. 43(4):610-8.
Myzak MC, W Dashwood M, Orner GA, Ho E, Dashwood RH.  2006.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.. FASEB J. 20(3):506-8.
Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH.  2002.  Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).. Mutat Res. 506-507:121-7.
Dashwood RH.  1999.  Early detection and prevention of colorectal cancer (review).. Oncol Rep. 6(2):277-81.